Drug profile · INN
efbemalenograstim alfa-vuxw
RYZNEUTA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
efbemalenograstim alfa-vuxw (RYZNEUTA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN efbemalenograstim alfa-vuxw
Brand RYZNEUTA
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is efbemalenograstim alfa-vuxw?
efbemalenograstim alfa-vuxw (RYZNEUTA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for efbemalenograstim alfa-vuxw?
RYZNEUTA is a marketed brand name for efbemalenograstim alfa-vuxw. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of efbemalenograstim alfa-vuxw?
efbemalenograstim alfa-vuxw has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.